August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
August 14, 2019 — People enrolled in a large clinical hypertension management trial were half as likely to control their ...
August 6, 2019 — Blood pressure monitoring might one day become as easy as taking a video selfie, according to new ...
July 29, 2019 — High blood pressure among children is on the rise and a lack of research about how to treat it has left ...
July 16, 2019 — Elevated blood pressure and cholesterol levels in young adulthood may lead to an increased risk of heart ...
July 3, 2019 — The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to ...
June 14, 2019 — Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its lead ...
June 6, 2019 — Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the ...
June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I ...
June 3, 2019 — Researchers at University of California San Diego School of Medicine found higher blood pressure and ...
May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical ...
May 15, 2019 — Renal artery denervation (RDN) was found to be safe when employed with pulmonary vein isolation (PVI) to ...
April 22, 2019 — New guidelines that classified more children as having elevated blood pressure are better at ...
March 12, 2019 — V-Wave Ltd. announced that renowned heart failure cardiologist William T. Abraham, M.D., is joining V ...
February 20, 2019 — California-based Vascular Dynamics Inc. (VDI) is sponsoring a new clinical trial, called CALM-2 ...